NCT04151940
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Recurrent Lung Non-Small Cell Carcinoma
Explore clinical trials studying Recurrent Lung Non-Small Cell Carcinoma. Study availability and eligibility vary by location and protocol.
47 public trials
11 recruiting studies
Recurrent Lung Non-Small Cell Carcinoma trial results
NCT03191149
- Conditions
- Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
NCT05098210
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Bronchial Neoplasms, Carcinoma, Bronchogenic, +46 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Recruiting
MOv19-BBz CAR T Cells in FRa+ Cancers
NCT07116057
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +14 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT05786924
- Conditions
- Acquired Resistance to KRAS G12C Inhibitor, BRAF, BRAF Gene Mutation, +61 more
- Locations
-
- Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
- The Angeles clinic - A cedars SINAI AFFILIATE Los Angeles, California, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California, San Francisco (UCSF) San Francisco, California, United States
NCT05570825
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT05642572
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
Recruiting
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
- Locations
-
- Mayo Clinic in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Recruiting
Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
NCT06616623
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States